Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8SZL

Human liver-type glutaminase (Apo form)

Summary for 8SZL
Entry DOI10.2210/pdb8szl/pdb
EMDB information40920
DescriptorGlutaminase liver isoform, mitochondrial (1 entity in total)
Functional Keywordsmetabolic, cancer, hydrolase
Biological sourceHomo sapiens (human)
Total number of polymer chains4
Total formula weight265638.88
Authors
Feng, S.,Aplin, C.,Nguyen, T.-T.T.,Milano, S.K.,Cerione, R.A. (deposition date: 2023-05-30, release date: 2024-03-13)
Primary citationFeng, S.,Aplin, C.,Nguyen, T.T.,Milano, S.K.,Cerione, R.A.
Filament formation drives catalysis by glutaminase enzymes important in cancer progression.
Nat Commun, 15:1971-1971, 2024
Cited by
PubMed Abstract: The glutaminase enzymes GAC and GLS2 catalyze the hydrolysis of glutamine to glutamate, satisfying the 'glutamine addiction' of cancer cells. They are the targets of anti-cancer drugs; however, their mechanisms of activation and catalytic activity have been unclear. Here we demonstrate that the ability of GAC and GLS2 to form filaments is directly coupled to their catalytic activity and present their cryo-EM structures which provide a view of the conformational states essential for catalysis. Filament formation guides an 'activation loop' to assume a specific conformation that works together with a 'lid' to close over the active site and position glutamine for nucleophilic attack by an essential serine. Our findings highlight how ankyrin repeats on GLS2 regulate enzymatic activity, while allosteric activators stabilize, and clinically relevant inhibitors block, filament formation that enables glutaminases to catalyze glutaminolysis and support cancer progression.
PubMed: 38438397
DOI: 10.1038/s41467-024-46351-3
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.12 Å)
Structure validation

239492

數據於2025-07-30公開中

PDB statisticsPDBj update infoContact PDBjnumon